neurovax vaccine designed treat patients multiple sclerosis developed immune response biopharma inc currently phase ii clinical trials neurovax designed stimulate regulatory tcells suppress autoreactive tcells development program neurovax terminated company developing vaccine filed bankruptcy work neurovax developed immune response biopharma inc granted us patent methods treating autoimmune diseases licensed tcr technology ohsu december us fda granted neurovax fda pediatric orphan designation february fda fast track designation antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikineurovax